Headache News and Research

Latest Headache News and Research

New machine learning-based approach to predict recovery time of sports-related concussions

The prevalence of concussions in sports is well known. So, too, is the challenge clinicians and others face when they have to decide when an athlete can return to the game after a head injury.

8 Mar 2019

Ebola survivors in Liberia have higher prevalence of health issues, study shows

Survivors of Ebola virus disease in Liberia had a higher prevalence of certain health issues--including uveitis (eye redness and pain), abdominal, chest, neurologic, and musculoskeletal abnormalities upon physical exam--when compared to a control group of household and community members who did not have a history of EVD, according to findings from an ongoing study published in the New England Journal of Medicine.

8 Mar 2019

New protocol could help physicians to rule out bacterial infections in infants

A new protocol could help emergency room physicians to rule out life-threatening bacterial infections among infants up to 2 months of age who have fevers, potentially eliminating the need for spinal taps, unnecessary antibiotic treatments or expensive hospital stays.

18 Feb 2019

Beer before wine does not change hangover severity

Despite popular belief, drinking beer before wine does not reduce the severity of veisalgia, otherwise known as a hangover, the following day.

8 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Tick’s salivary glands could become key research tools for studying virus transmission

The salivary glands of some tick species could become important research tools for studying how viruses are transmitted from ticks to mammals, and for developing preventive medical countermeasures.

30 Jan 2019

Investigational Ebola treatment found to be safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

25 Jan 2019

Onset of migraine with aura before age of 50 not linked to risk of ischemic stroke

Migraine with aura was associated with an increased risk of ischemic stroke in the Atherosclerosis Risk in Communities study, but a recent post-hoc analysis published in Headache reveals unexpected results suggesting that onset of such migraines before age 50 years is not associated with such risk.

24 Jan 2019

Telemedicine may improve patient satisfaction with medical care, study suggests

Cardiovascular disease pervades Appalachia, yet many Appalachians live far from any heart and vascular specialist. Follow-up doctor's visits in the weeks after cardiovascular surgery can involve hours-long drives down narrow, winding roads.

3 Jan 2019

New treatment for adults with rare, life-threatening blood disease receives FDA approval

The U.S. Food and Drug Administration today approved Ultomiris (ravulizumab) injection for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH), a rare and life-threatening blood disease.

21 Dec 2018

IU study focuses on repetitive subconcussive head impacts in sports

A new study by Indiana University researchers has found that eyeball and eyelid movement, or oculomotor function, which is used to detect symptomless brain injury, can be impaired by mild, repetitive head impacts in football players. But the function may adapt mid-season, even as athletes continue to incur head impacts.

21 Dec 2018

Pregnant women and extremely obese people at high risk of flu complications

Pregnant women and the extremely obese are among those at high risk for complications from the flu - including death - and should be tested and begin antiviral treatment promptly if they are sick enough to be hospitalized with flu symptoms, according to updated guidelines released by the Infectious Diseases Society of America.

19 Dec 2018

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's Sofia 2 Lyme+ FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi, Borrelia garinii, and Borrelia afzelii from serum and plasma specimens.

19 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Study compares pain-related diagnoses in First Nations and non-First Nations children, youth

First Nations children and youth are experiencing more pain than non-First Nations children, but do not access specialist or mental health services at the same rate as their non-First Nations peers, found new research published in CMAJ.

10 Dec 2018

New strategies may improve performance of CAR-T cell therapy in treating cancer

Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy in treating cancer. They are presenting results of their preclinical research at the 2018 annual meeting of the American Society of Hematology in San Diego.

3 Dec 2018

Nasal surgery can reduce or eliminate chronic headaches in selected patients

Nasal surgery to relieve obstructed breathing can reduce or eliminate chronic headaches in selected patients, reports a paper in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

29 Nov 2018

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

Researchers harness visible light to develop safer building block for drug discovery

When you reach for a bottle of acetaminophen, you may be looking for relief from a headache. But if you take more than what is recommended, the drug can damage your liver.

22 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

Headache News and Research

Latest Headache News and Research

New machine learning-based approach to predict recovery time of sports-related concussions

Ebola survivors in Liberia have higher prevalence of health issues, study shows

New protocol could help physicians to rule out bacterial infections in infants

Beer before wine does not change hangover severity

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

Tick’s salivary glands could become key research tools for studying virus transmission

Investigational Ebola treatment found to be safe in adults

Onset of migraine with aura before age of 50 not linked to risk of ischemic stroke

Telemedicine may improve patient satisfaction with medical care, study suggests

New treatment for adults with rare, life-threatening blood disease receives FDA approval

IU study focuses on repetitive subconcussive head impacts in sports

Pregnant women and extremely obese people at high risk of flu complications

Quidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with Sofia 2 analyzer

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Study compares pain-related diagnoses in First Nations and non-First Nations children, youth

New strategies may improve performance of CAR-T cell therapy in treating cancer

Nasal surgery can reduce or eliminate chronic headaches in selected patients

FDA approves new drug for treatment of rare autoimmune disorder

Researchers harness visible light to develop safer building block for drug discovery

FDA approves antibacterial drug to treat travelers' diarrhea

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Headache News and Research

Latest Headache News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in